ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.695
      -0.11%
      Bitcoin
      64,976.00
      -0.25%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. AVEO Pharmaceuticals Inc (AVEO)

      7. AVEO Pharmaceuticals Inc (AVEO) News

      AVEO

      AVEO Pharmaceuticals (AVEO)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AVEO
      DateTimeSourceHeadlineSymbolCompany
      08/10/20204:05PMBusiness WireAVEO Oncology Reports Second Quarter 2020 Financial Results and Provides Business UpdateNASDAQ:AVEOAVEO Pharmaceuticals Inc
      08/10/20204:03PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      08/05/20204:05PMBusiness WireAVEO Oncology Announces $2.8M Development Milestone Earned from Kyowa KirinNASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/30/20204:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/30/20204:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/30/20204:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/30/20204:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/30/20204:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/29/20205:23PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/29/20205:22PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/24/20205:04PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/22/20205:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/22/20205:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/22/20205:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/22/20205:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/22/20205:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/22/20205:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/22/20205:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/19/20204:05PMBusiness WireAVEO Announces Closing of Public Offering of Common Stock and Partial Exercise of Option to Purchase Additional SharesNASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/19/202012:11PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/17/20205:11PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/16/202010:38PMBusiness WireAVEO Announces Pricing of $44.6 Million Public Offering of Common StockNASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/15/20204:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/15/20204:27PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/15/20204:05PMBusiness WireAVEO Announces Proposed Public Offering of Common StockNASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/10/20205:20PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/01/20204:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/01/20201:15PMBusiness WireAVEO Oncology Announces FDA Acceptance for Filing of a New Drug Application for Tivozanib as a Treatment of Relapsed or Refra...NASDAQ:AVEOAVEO Pharmaceuticals Inc
      05/29/20208:32AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      05/29/20207:05AMBusiness WireAVEO Oncology Announces Phase 1b/2 DEDUCTIVE Study of FOTIVDA® (tivozanib) in Combination with IMFINZI® (durvalumab) in Pre...NASDAQ:AVEOAVEO Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:AVEO